Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06133049 · ClinicalTrials.gov registry record
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
A clinical trial of Multiple Sclerosis, sponsored by Bristol-Myers Squibb.
- Active
- Registry status
- 2,961
- Enrollment target
- 1
- Study location
NCT06133049 is a study of Multiple Sclerosis that is active but no longer recruiting, run by Bristol-Myers Squibb. The registered enrollment target is 2,961 participants, above the 576-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (414% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06133049, a study of Multiple Sclerosis, is active but no longer recruiting, sponsored by Bristol-Myers Squibb.
- ACTIVE NOT RECRUITING
- Registry status
- 2,961 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this retrospective observational cohort study is to assess pregnancy and infant outcomes in three groups: the first is women with multiple sclerosis (MS) who were exposed to ozanimod during pregnancy; the second is women with MS exposed to select other disease-modifying therapies (DMTs) during pregnancy; the third is women with MS not exposed to any DMTs during pregnancy. This study will use data from a large US healthcare claims database.
Conditions Studied
Interventions
- DRUG Ozanimod
- DRUG Select DMTs other than ozanimod
- DRUG No DMTs
Study Locations (1)
Minnesota
- OptumInsight Life Sciences Inc - Eden Prairie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,961 participants |
| Start Date | 2021-03-16 |
| Est. Completion | 2031-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06133049
The ClinicalTrials.gov registry entry for NCT06133049 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,961 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 576-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (414% higher). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 3 interventions - of which Ozanimod is the first listed.
NCT06133049 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06133049 about?
NCT06133049 is a clinical study titled "A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants". The purpose of this retrospective observational cohort study is to assess pregnancy and infant outcomes in three groups: the first is women with multiple sclerosis (MS) who were exposed to ozanimod during pregnancy; the second is women with MS exposed to select other disease-modifying therapies (DMT...
What is the current status of trial NCT06133049?
This trial is currently active not recruiting. The enrollment target is 2,961 participants. The study started on 2021-03-16. Estimated completion is 2031-08-31.
What conditions does trial NCT06133049 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT06133049?
The interventions under investigation include: Ozanimod (DRUG), Select DMTs other than ozanimod (DRUG), No DMTs (DRUG).
Who is sponsoring clinical trial NCT06133049?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06133049 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.